心血管病学进展2024,Vol.45Issue(1) :24-26.DOI:10.16806/j.cnki.issn.1004-3934.2024.01.007

纤维性纵隔炎致肺动脉狭窄研究现状

Pulmonary Artery Stenosis Caused by Fibrosing Mediastinitis

孙策 卢志雄 汤银江
心血管病学进展2024,Vol.45Issue(1) :24-26.DOI:10.16806/j.cnki.issn.1004-3934.2024.01.007

纤维性纵隔炎致肺动脉狭窄研究现状

Pulmonary Artery Stenosis Caused by Fibrosing Mediastinitis

孙策 1卢志雄 1汤银江2
扫码查看

作者信息

  • 1. 云南省滇东北区域中心医院心血管内科,云南昭通 657000
  • 2. 云南省阜外心血管病医院呼吸与肺血管科,云南昆明 650000
  • 折叠

摘要

纤维性纵隔炎(FM)又称为硬化性纵隔炎或纵隔纤维化,是以纵隔内纤维组织良性增生为特点的一类罕见疾病.随纵隔内纤维组织增生,血管、气管及食管受压后逐渐出现相应压迫症状.该疾病进展早期可无明显临床表现,易漏诊.因FM较为罕见,病例样本量小,故目前临床研究有限,病因及发病机制尚不明确且无规范诊疗指南.现就FM致肺动脉狭窄研究现状做阐述,旨在对FM相关性肺动脉狭窄诊疗提供指导意义.

Abstract

Fibrosing mediastinitis(FM)is also known as sclerosing mediastinitis or mediastinal fibrosis,it is a rare disease characterized by benign hyperplasia of mediastinal fibrous tissue.With the proliferation of fibrous tissue in the mediastinum,corresponding compression symptoms gradually appear after compression of blood vessels,trachea and esophagus.In the early stage of disease progression,there may be no clinical manifestations obviously,and it is easy to misdiagnose.Due to the rarity of FM and the small sample size of cases,the clinical research is limited,the etiology and pathogenesis are still unclear,and there is no standardized diagnosis and treatment guideline of FM.This article expounds the research status of pulmonary artery stenosis caused by FM,aiming to provide guidance for the diagnosis and treatment of pulmonary artery stenosis associated with FM.

关键词

纤维性纵隔炎/纤维组织增生/肺动脉狭窄/诊疗

Key words

Fibrosing mediastinitis/Proliferation of fibrous tissue/Pulmonary artery stenosis/Diagnosis and treatment

引用本文复制引用

出版年

2024
心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
参考文献量17
段落导航相关论文